Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a Ritonavir-Boosted Protease Inhibitor Regimen
2014-004331-39Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir in human immunodeficiency virus infection (HIV), Human immunodeficiency virus infection type 1, sponsored by Vall d'Hebron Research Institute. Started Nov 2014; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2014-004331-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004331-39.